印度正品代购提示，泊马度胺（Pomalid）是由美国Celgene制药公司开发的新一代的免疫调节剂 （IMiD），由于该药在针对难治复发性多发性骨髓瘤 （RRMM）的临床试验中显现出了令人鼓舞的效果，所以其在2013年泊马度胺（Pomalid）就被美国FDA同意用于至少通过两种医治无效 （包括来那度胺和硼替佐米 ）和最后一次医治后60d内病情恶化的患者。至此，该药也成为了众多多发性骨髓瘤患者医治的又一新挑选。

Pomalid (Pomalid) is a new generation of immune modulator (IMiD) developed by Celgene Pharmaceuticals in the United States. As Pomalid showed encouraging results in clinical trials for refractory recurrent multiple myeloma (RRMM), Pomalid is a new generation of immune modulator (IMiD) developed by Celgene Pharmaceuticals in the United States. So Pomalid was approved by the US FDA in 2013 for use in patients who had failed at least two treatments (including renalidomide and bortezomib) and who had progressed within 60 days of their last treatment. So far, the drug has become a new option for many patients with multiple myeloma.

泊马度胺

　　泊马度胺（Pomalid）是继沙利度胺、来那度胺之后的第三代免疫调节剂（IMiD），该药品显现出共同的抗感染/免疫调节/抗肿瘤增生/抗血管生成等效果，并在泊马度胺（Pomalid）针对难治复发性MM（RRMM）的临床试验中显现出显著的效果。泊马度胺（Pomalid）不单对MM显现了很好的效果，对骨髓增生反常综合征/急性粒细胞白血病/缓慢淋巴细胞白血病/非霍奇金淋巴瘤/骨髓纤维化等非实体瘤的医治也很有用，还有对已采纳其他医治办法，但效果不理想且无法承受移植的免疫球蛋白轻淀粉样变性疾病也是非常好的挑选。

　　印度正品代购提示：泊马度胺胶囊有什么副效果呢？

　　服用泊马度胺（Pomalid）也会产生必定的副效果或不良反应，其间泊马度胺（Pomalid）最常见的副效果有：中性粒细胞减少/疲惫/虚弱/红细胞计数降低/便秘/腹泻/血小板减少/上呼吸道感染/背部疼痛/发热等。

　　通常在服用泊马度胺（Pomalid）后呈现这些副效果的状况都是轻微的，并且这些副效果是患者能够耐受的。但因为每位患者的个人体质及病情的不同，如果单个患者在服用泊马度胺（Pomalid）后呈现难以耐受的副效果，可考虑中止用药，可是其间隔时间不要超越两周，一般情况下，停用后再次服用该药物进行医治，副效果会减轻很多。若难以承受，患者应及时就医，寻求医生帮助。

These side effects are usually mild after taking Pomalid and can be tolerated by the patient. But because each patient's individual constitution and condition is different, if a single patient in taking pomalidomide (Pomalid) after the side effect is intolerable, can consider to discontinue the drug, but the interval should not exceed two weeks, in general, after disuse again take the drug for treatment, the side effect will be reduced a lot. If it becomes unbearable, the patient should seek medical help.